<DOC>
	<DOCNO>NCT00211367</DOCNO>
	<brief_summary>Radiation retinopathy disease retina . It occur people receive exposed radiation near eye . The blood vessel abnormal may grow lead scar loss central vision . Currently , treatment radiation retinopathy laser photocoagulation . This treatment find limited use type condition . Compassionate use anecortave acetate injection consider prevent growth blood vessel retina .</brief_summary>
	<brief_title>Treatment Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg )</brief_title>
	<detailed_description>Patients receive injection 15 mg Anecortave acetate behind eye treat ( `` study eye '' ) . They evaluate every six month determine condition stable worse . Following injection study medication , patient require come see study physician . The investigator study staff call patient day follow injection make sure adverse effect injection . Patients come Month 1 Month 3 follow-up visit . At Month 3 follow-up visit , patient show stability improvement , may offer either thermal laser Photodynamic Therapy . They remain study remain eligible repeat injection Anecortave Acetate Month 6 visit . Patients see Month 6 Re-treatment Evaluation Visit . If condition stable , offer re-injection study medication receive earlier . If Patients show stability improvement Month 6 visit , may offer thermal laser Photodynamic Therapy conjunction Anecortave Acetate injection . Patients come back Month 1 Month 3 visit Exit Visit , necessary . If patient 's condition worse , patient exit study offer standard treatment .</detailed_description>
	<mesh_term>Eye Injuries</mesh_term>
	<mesh_term>Anecortave</mesh_term>
	<criteria>1 . Clinical diagnosis radiation retinopathy . 2 . Patients must 18 year age older receive treatment . 3 . Visual acuity 20/30 20/320 study eye Early Treatment Diabetic Retinopathy Study ( ETDRS ) visual acuity chart 4 . Visual acuity 20/800 good fellow eye ETDRS visual acuity chart . 1 . Patient significantly compromise visual acuity study eye due concomitant ocular condition . 2 . Patients undergone intraocular surgery within last 2 month 3 . Patient participate investigational drug study . 4 . Use investigational drug treatment relate unrelated condition within 30 day prior receipt study medication . 5 . Inability obtain photographs document choroidal neovascularization ( CNV ) ( include difficulty venous access ) 6 . Patient significant liver disease uremia . 7 . Patient known adverse reaction fluorescein indocyanine green iodine . 8 . Patient history medical condition would preclude schedule visit completion study 9 . Patient insertion scleral buckle study eye 10 . Patient receive radiation treatment 11 . Patient anticoagulant therapy exception aspirin 12 . Patient pregnant nursing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Radiation Retinopathy</keyword>
</DOC>